Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Accepted on 21 Apr 2025

Bibliometric analysis and visualization of Connexin 43 in the field of solid tumor research (2000-2024)

in Cancer Immunity and Immunotherapy

Caiqi Huang
Yanhui Feng
Xiaoman Liu
Zhesi Xiao
Zhengjia Lu
Lu Wang
Jia Ming

Frontiers in Immunology

doi 10.3389/fimmu.2025.1588828

Original Research

Accepted on 21 Apr 2025

Tandem CAR T-cells targeting CD19 and NKG2DL can overcome CD19 antigen escape in B-ALL

in Cancer Immunity and Immunotherapy

Jennifer Bolsée
Benjamin Violle
Céline Jacques-Hespel
Thuy Nguyen
Caroline Lonez
Eytan Breman

Frontiers in Immunology

doi 10.3389/fimmu.2025.1557405

Original Research

Accepted on 21 Apr 2025

Toll-like Receptor 3 Activation Enhances Antitumor Immune Response in Lung Adenocarcinoma through NF-κB Signaling Pathway

in Cancer Immunity and Immunotherapy

Ang Li
Xiyao Liu
Hongjiao Wu
Xiaoguang Liu
Zhi Zhang
Xuemei Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1585747

Mini Review

Accepted on 21 Apr 2025

Mechanisms of Autoimmune-Mediated Paraneoplastic Syndromes: Immune Tolerance and Disease Pathogenesis

in Cancer Immunity and Immunotherapy

Cesar Perez Bucio
Anish Behere
Nils Landegren

Frontiers in Immunology

doi 10.3389/fimmu.2025.1608934

Original Research

Accepted on 21 Apr 2025

CBD promotes antitumor activity by modulating tumor immune microenvironment in HPV associated Head and Neck Squamous Cell Carcinoma

in Cancer Immunity and Immunotherapy

Prakriti Sen
Sayed Sadat
Koji Ebisumoto
Riyam Al Msari
Sayuri Miyauchi
Souvick Roy
Pardis Mohammadzadeh
Kristin Lips
Takuya Nakagawa
Robert Saddawi Konefka

Frontiers in Immunology

doi 10.3389/fimmu.2025.1528520

Mini Review

Accepted on 21 Apr 2025

Ultrasound-assisted Immunotherapy for Malignant Tumor

in Cancer Immunity and Immunotherapy

XIAOWEN CAI
Yujie Liu
Guosheng Luo
Zhanwang Yu
Cheng Jiang
Chuanshan Xu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1547594

Mini Review

Accepted on 21 Apr 2025

The distinct role of IL-34 and IL-35 in gastric cancer

in Cancer Immunity and Immunotherapy

Zhiyun He
Jie Dang
Xiang Cui
Bo Li
Shisan Bao
Jingchun Fan

Frontiers in Immunology

doi 10.3389/fimmu.2025.1559508

Systematic Review

Accepted on 21 Apr 2025

A Comprehensive Bibliometric Analysis of Ferroptosis in Tumor Resistance: Development and Emerging Trends

in Cancer Immunity and Immunotherapy

Liangyun Xie
Yafei Zhang
Xiedong Niu
Kang Yuan
Wenyao Li
Jun Yao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1580222

Original Research

Accepted on 21 Apr 2025

Fusobacterium nucleatum downregulated MLH1 expression in colorectal cancer by activating autophagy-lysosome pathway

in Cancer Immunity and Immunotherapy

Tingting Ding
Minkang Wu
Li Zhao
Hu Liu
Xuanke Cao
Jing Guo
Xingchen Zhu
Lamei Zhao
Heping Zhang
Yaohui Gao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1586146

Systematic Review

Accepted on 21 Apr 2025

Efficacy of Neoadjuvant, Adjuvant, and Perioperative Immunotherapy in Non-Small Cell Lung Cancer Across Different PD-L1 Expression Levels: A Systematic Review and Meta-Analysis

in Cancer Immunity and Immunotherapy

Zhenlong Zhang
Yuchen Lin
Shuchen Chen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1569864

Original Research

Accepted on 21 Apr 2025

Development of a Lung Immune Prognostic Index-Based Nomogram Model for Predicting Overall Survival and Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Treated with Sintilimab

in Cancer Immunity and Immunotherapy

Jian Xu
tingting peng
fan kaikai
dou yuxiao
Lingti Kong
Ran Sang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1569689

Original Research

Accepted on 21 Apr 2025

Integrative Single-cell and Spatial Transcriptomics Analysis Reveals MDK-NCL Pathway's Role in Shaping the Immunosuppressive Environment of Lung Adenocarcinoma

in Cancer Immunity and Immunotherapy

Yu Fu
Song Li
Yikang Zhao
Xiran Zhang
Xiaolu Mao
Ran Xu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1546382

Original Research

Accepted on 21 Apr 2025

Efficacy prediction of systemic immune-inflammation index (SII) and prognostic nutritional index (PNI) in breast cancer patients and their variations after Neoadjuvant chemotherapy

in Cancer Immunity and Immunotherapy

Jingyi Ni
Xue Qi
Conghui Jin
Weiwei Xu
Xinghui Li
Li Song
Xunlei Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1514736

Original Research

Accepted on 18 Apr 2025

Decoding Multiple Myeloma: Single-Cell Insights into Tumor Heterogeneity, Immune Dynamics, and Disease Progression

in Cancer Immunity and Immunotherapy

Zhenzhen Zhao
Zhijie Zhao
Zhiheng Lin
Lu Fan
Xiahou Zhikai
Yujiang Dong
Weiying Bao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1584350

204 views

Mini Review

Accepted on 18 Apr 2025

Unraveling the Immunosuppressive Microenvironment of Glioblastoma and Advancements in Treatment

in Cancer Immunity and Immunotherapy

Dongxin Jiang
Yunqian Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1590781

159 views

Review

Accepted on 18 Apr 2025

Recent Advances in Biomarkers for Predicting the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer

in Cancer Immunity and Immunotherapy

Jiacheng Zhang
Zehao Song
Yuanjie Zhang
Chentong Zhang
Qi Xue
Guochao Zhang
Fengwei Tan

Frontiers in Immunology

doi 10.3389/fimmu.2025.1554871

101 views